Prediction Case File
YouTubeTracking Live

MU Must Reclaim $638 By Tuesday—Or I'm WRONG! 🚨📉

1 extracted signal · 0 resolved · 1 still active

Stocks with Josh profile imageStocks with JoshIndependent analyst profile
Source published
21 Nov 2026, 18:34 UTC
Recorded by Tahlil Plus
21 Nov 2026, 20:32 UTC
Video preview for MU Must Reclaim $638 By Tuesday—Or I'm WRONG! 🚨📉
Source overview

AI-generated source summary

The speaker analyzes Micron Technology (MU) on a weekly timeframe, focusing on Fibonacci retracement levels. The primary thesis is that MU needs to hold or reclaim the 638.44 level (the golden pocket 0.65 Fib level). If it fails to break back above 638.44 by early next week, the bullish move is considered broken, and the price is expected to trend lower toward the 514 support level, confirming a broader bearish continuation.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Tracking Live
Signals
1
Extracted from this source
Open
1
Still being tracked
Successful
0
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
—
0 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Source processing completed

    Source analysis and structured extraction completed.

  5. Live evaluation in progress

    1 signal remains active.

Analyst snapshot

Stocks with Josh

Platform-wide history, separate from this source evaluation.

Reliability
—
Tracked signals
15
Historical success
—
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail